 |
Previous Article | Next Article 
The Journal of Neuroscience, 2002, 22:RC213:1-6
RAPID COMMUNICATION
P/Q-Type Calcium-Channel Blockade in the Periaqueductal
Gray Facilitates Trigeminal Nociception: A Functional Genetic
Link for Migraine?
Yolande E.
Knight,
Thorsten
Bartsch,
Holger
Kaube, and
Peter J.
Goadsby
Headache Group, Institute of Neurology, London, WC1N 3BG,
United Kingdom
 |
ABSTRACT |
The discovery of mis-sense mutations in the 1A subunit of the
P/Q-type calcium channel in patients with familial hemiplegic migraine
indicates the potential involvement of dysfunctional ion channels in
migraine. The periaqueductal gray (PAG) region of the brainstem
modulates craniovascular nociception and, through its role in the
descending pain modulation system, may contribute to migraine
pathophysiology. In this study we sought to investigate the possible
link between the genetic mutations found in migraineurs and the PAG as
a modulator of craniovascular nociception. We microinjected the
P/Q-type calcium-channel blocker -agatoxin IVA into the rat ventrolateral PAG (vlPAG). We examined its effect on the nociceptive transmission of second-order neurons recorded in the trigeminal nucleus
caudalis and activated by stimulation of the parietal dura
mater. After injection of agatoxin into the vlPAG
(n = 20) responses to dural stimulation were
facilitated by 143% (p < 0.0001) for
A -fiber activity and 180% for C-fiber activity
(p < 0.05). Similarly, spontaneous
background activity increased by 163% (p < 0.0001). These results demonstrate that P/Q-type calcium channels in
the PAG play a role in modulating trigeminal nociception and suggest a
role for dysfunctional P/Q-type calcium channels in migraine pathophysiology.
Key words:
migraine; electrophysiology; periaqueductal gray; P/Q-type calcium channel; trigeminal; nociception
 |
INTRODUCTION |
It
has been suggested that migraine may involve a calcium channelopathy.
Although the gene CACNA1A has also been implicated in normal
migraine, approximately one-half of patients with familial hemiplegic
migraine carry mis-sense mutations in this gene, which encodes the
1A subunit of the voltage-gated calcium channel (May et al., 1995 ;
Ophoff et al., 1996 ; Nyholt et al., 1998 ; Kors et al., 2001 ).
CACNA1A encodes the pore-forming protein of P/Q-type calcium channels.
These are a heterogeneous class of calcium channel involved in
controlling neurotransmitter release throughout the mammalian brain
(Dunlap et al., 1995 ; Craig et al., 1998 ). They are located on cell
bodies, dendrites, and predominantly presynaptic terminals and are
widespread in the CNS, including regions involved in nociception such
as the trigeminal ganglion, spinal trigeminal nucleus, spinal cord
dorsal horn, nucleus raphe magnus, and ventral periaqueductal gray
(PAG) (Hillman et al., 1991 ; Westenbroek et al., 1995 ; Craig et al.,
1998 ). P/Q-type calcium channels at the spinal level have been shown to
affect nocifensive behavior and the hyperexcitability of nociceptive
dorsal horn neurons (Malmberg and Yaksh, 1994 ; Nebe et al., 1999 ).
However, the role of P/Q-type calcium channels in the supraspinal
modulation of nociception remains unclear.
It has been postulated that the brainstem plays a pivotal role in
migraine (Goadsby et al., 1991 ; Welch et al., 2001 ). Direct evidence of
a prominent role for the brainstem, particularly PAG, in
migraine has been provided by functional imaging studies of patients
(Weiller et al., 1995 ; May et al., 1998 ; Bahra et al., 2001 ; Welch et
al., 2001 ). Also, it is well documented that stimulation (Raskin et
al., 1987 ) or lesions in the PAG can produce migraine-like headache in
non-migraineurs (Haas et al., 1993 ; Veloso et al., 1998 ). These
clinical studies indicate a role for the PAG in migraine and
particularly the nociceptive processes of headache.
The PAG has been shown to modulate nociception in various experimental
animal models of pain (Reynolds, 1969 ; Behbehani, 1995 ). Of particular
importance to trigeminal nociceptive modulation is the ventrolateral
subdivision of the PAG (vlPAG). It modulates trigeminal nociception in
the same model of craniovascular pain as used in this study and
selectively receives input from trigeminovascular afferents (Oliveras
et al., 1974 ; Keay and Bandler, 1998 ; Hoskin et al., 2001 ; Knight and
Goadsby, 2001 ). PAG modulation of trigeminal nociception has been most
thoroughly studied for its inhibitory effects and less so for
trigeminal pronociceptive effects (Behbehani, 1995 ). An aim in this
study was to further characterize vlPAG modulation of trigeminal
nociceptive transmission and, therefore, to investigate a possible
mechanism by which the PAG could produce headache.
In an attempt to draw together a genetically driven, central attribute
for migraine pathophysiology with a focus on nociceptive transmission,
we investigated the effect of blockade of ventrolateral PAG P/Q-type
calcium channels in a model of trigeminovascular activation in the rat.
In our model, we activated trigeminal nociceptive neurons by
stimulating the supratentorial parietal dura adjacent to the middle
meningeal artery (MMA), recorded the activity of second-order neurons
in the trigeminal nucleus caudalis, and studied their response to
blockade of P/Q-type calcium channels in the PAG.
 |
MATERIALS AND METHODS |
All experiments were performed under a project license issued by
the UK Home Office under the Animals (Scientific Procedures) Act of
1986. A total of 20 male Sprague Dawley rats weighing 329 ± 9 gm
(mean ± SD) were anesthetized [Sagatal (pentobarbitone sodium),
65 mg/kg, i.p. induction; maintenance with -chloralose, 15 mg/kg,
i.v.] and, during electrophysiological recording, paralyzed [Pavulon
(pancuronium bromide) 1 mg/kg initially, then 0.4 mg/kg maintenance].
Surgery. The head of the animal was fixed in a stereotaxic
frame. The parietal dura adjacent to the MMA was exposed through a small cranial window and stimulated. For the multibarreled
microinjection unit to enter the brain a burr hole was made in the
cranium and the superior sagittal sinus was pierced to allow
penetration. The muscles of the dorsal neck were separated and the dura
was incised to expose the brain stem at the level of the caudal medulla.
MMA stimulation. To activate trigeminal primary afferents,
the dura was stimulated with a Grass S88 stimulator (Grass Instrument Co., Quincy, MA). A pair of bipolar electrodes was placed on the dura on either side of the MMA and electrical square-wave stimuli (0.5-0.6 Hz) of 0.5-2 msec duration up to 10 V were applied.
Trigeminal nucleus caudalis recording. Custom made tungsten
in glass electrodes with a tip diameter ranging from 10 to 20 µm and
impedances ranging from 400 to 800 k were used to record the
activity of trigeminal nociceptive neurons in the trigeminal nucleus
caudalis. Extracellular recordings of single or multiple neurons were
made from MMA stimulation-evoked or spontaneous nerve signals. Signals
were fed into a window discriminator connected to an
analog-to-digital interface (CED Power 1401plus; Cambridge Electronic Design, Cambridge, UK) and an IBM-compatible
computer. Full spikes were discriminated by means of an electronic
delay unit. Poststimulus time histograms (PSTHs) and peristimulus time histograms of neural activity were displayed and analyzed using conventional software (Spike 2.01; Cambridge Electronic Design).
PAG microinjection. A multibarreled glass capillary unit was
used for microinjection of drugs into the ipsilateral PAG. The stereotaxic positioning of the multibarrel unit was aimed at
co-ordinates for the caudal ventrolateral PAG according to the atlas of
Paxinos and Watson (1998) : 1.36 mm rostral and 4.2 mm dorsal from the interaural point, 0.5-0.7 mm left of the midline. Drugs were injected over a period of 30-120 sec for a volume range of 50-600 nl.
Characterization of neurons. Trigeminal nucleus caudalis
(TNC) neurons were characterized for their cutaneous and deep receptive fields. The cutaneous facial receptive field, including the cornea, was
assessed in all three trigeminal innervation territories. The receptive
field was mapped by applying non-noxious and noxious stimuli.
Non-noxious stimuli were applied by gentle brushing and by applying
light pressure with a blunt probe. Noxious mechanical stimuli
consisted of pinching with forceps or applying heavy pressure deemed
painful when applied to humans. Neurons were classified as wide-dynamic
range (WDR) if they responded to non-noxious and noxious stimuli and as
nociceptive-specific neurons (NS) if they responded only to noxious
input (Hu et al., 1981 ).
Trains of 20 or 30 stimuli were delivered in 5 min intervals to assess
the baseline responses to dural stimulation. Stimulation latencies
corresponding to A - and C-fiber were 0-30 msec and 30-100 msec,
respectively. Spontaneous activity is presented as spikes per second
(in Hertz). Spontaneous activity was recorded within 120-180 sec
preceding the dural stimulation epoch.
Inhibition of evoked TNC activity after bicuculline injection in the
PAG was considered a functional connection between the region of PAG
microinjection and the recorded TNC neuron. Three baseline PSTHs were
collected to ensure reproducibility over time of responses to MMA
stimulation. Because agatoxin is an irreversible P/Q-type
calcium-channel blocker (Mintz et al., 1992 ), only one TNC neuronal
response in each animal was tested after the application of agatoxin
into the PAG.
Experimental protocol. The sequence of experimental events
were as follows: (1) three baseline collections; (2) bicuculline injection into PAG; (3) collections at 1, 5, 10, 15, 20, and 25 min
after bicuculline injection; (4) three new baseline collections; (5)
agatoxin or saline injection into the PAG; and (6) collections at 5, 10, 15, 20, 25, 30, 40, 50, and 60 min after agatoxin or saline injection.
Drug preparation and histology. Drugs were prepared as
follows: 0.4 mM bicuculline methiodide, pH
8.2-9.6 (Sigma, St. Louis, MO), 0.1 µM
-agatoxin IVA, pH 8.0-8.4 (Scientific Marketing Association, Barnet, Herts, UK), and 2% Pontamine Sky Blue, pH 8.0-8.7 (Sigma) in
100 mM sodium acetate were used. At the
completion of the experiment, an electrical lesion was made in the TNC
and a deposit of Pontamine Sky Blue was made in the PAG. The brain was
stored for 24-36 hr in a staining and fixing solution, frozen, cut
into 40 µm sections, and stained with neutral red or cresyl violet.
Statistical analysis. Data for A - and C-fiber responses
were normalized to 100% of baseline before statistical analysis. Data
for spontaneous activity were analyzed raw (Hertz), except in the
saline controls. Two ANOVAs for repeated measures were used to
independently determine the time course of significant drug
interventions for bicuculline and agatoxin. Statistical significance was set at p < 0.05. For ANOVA output, the data are
presented as F(df, n), where df
is degrees of freedom and n is the number of samples. A
two-sample Student's t test for post hoc
analysis was used to evaluate statistical significance compared with
baseline of bicuculline or agatoxin at the time of maximal effect. To
account for the large scale of firing rates across C-fiber samples
(3-810 Hz) postdrug responses were normalized to 100% and pooled; a
one-sample t test was then applied. Data are expressed as
mean ± SEM for a number (n) of observations. ANOVA,
paired sample, and one-sample t tests were performed using SPSS statistical software, version 9.0 (SPSS, Inc., Chicago, IL).
 |
RESULTS |
Recordings were made from 20 neurons (18 WDR and 2 NS) responsive
to dural stimulation with cutaneous receptive fields restricted to the
ophthalmic division of the trigeminal nerve, including the cornea
(n = 20). A total of 16 neurons showed input from
frontalis muscle. Neurons were found in the deep layers of the dorsal
horn of the C1/TNC transition zone at a mean
depth of 967 µm (range 470-1495 µm) (Fig.
1). PAG microinjection sites were
localized to the vlPAG, and three were in the ventral border of the
lateral PAG (Fig. 1).

View larger version (46K):
[in this window]
[in a new window]
|
Figure 1.
Histological confirmation of PAG microinjection
sites in the ventrolateral PAG (A), where each
blue dot represents one injection site. For the recording
sites in the deep layers of the TNC (B), each
red dot represents the site of one recording from
dura-responsive neurons. A typical example of a cutaneous facial
receptive field (C) that was restricted to the ophthalmic
division of the trigeminal nerve (red area) is shown.
D, Representative example of a Pontamine stain in the
vlPAG, showing volume spread of <0.4 mm at low and high magnification.
Aq, Aqueduct; vl, ventrolateral.
This illustration was adapted from Molander and Grant (1995) and
Paxinos and Watson (1998) .
|
|
Bicuculline injection in the vlPAG
To identify functional inhibitory projections from the PAG to the
TNC, bicuculline was injected into the vlPAG. Injection of bicuculline
(50-300 nl) into the vlPAG produced inhibition of the trigeminal
nociceptive response to dural stimulation. In A -fiber responses,
maximum inhibition was observed at 5 min after bicuculline injection
(F(19,7) = 8.321; p = 0.001). Maximum inhibition of mean spontaneous activity (MSA) was also
observed at 5 min (F(3.1,17) = 21.4;
p < 0.0001) (Fig. 2).
A -fiber responses were inhibited by 41 ± 4% of baseline,
ranging from 8 to 67% (n = 18; p < 0.0001). C-fiber inhibition was 50 ± 6%
(n = 11; p < 0.0001). Baseline MSA was
52 ± 4 Hz, ranging from 18 to 102 Hz. Bicuculline significantly
inhibited MSA to 24 ± 3 Hz, ranging from 4 to 95 Hz
(n = 17; p < 0.0001).

View larger version (14K):
[in this window]
[in a new window]
|
Figure 2.
Time course of the group response of TNC neurons
to bicuculline or agatoxin injection into the vlPAG, A activity
(A), and spontaneous activity
(B). Group data, expressed as mean ± SEM
(*p < 0.05; **p < 0.01;
paired t test), indicate significant differences
compared with baseline.
|
|
Agatoxin injection in the vlPAG
Microinjection of 400-600 nl of agatoxin into the vlPAG produced
a facilitation of the trigeminal nociceptive response to dural
stimulation and to spontaneous activity.
In A -fiber responses, facilitation became significant at 15 min
after agatoxin injection and was 122 ± 4%
(F(3,13)=7.375; p = 0.041). Maximal facilitation was observed at 60 min after injection and
ranged from 116 to 216% (mean, 143 ± 7%) (n = 14; p < 0.0001) (Fig. 2).
C-fiber facilitation was 180 ± 35% (n = 12;
t(11) = 2.277; p = 0.044). Facilitation compared with baseline was significant 5 min after
agatoxin injection and was 165 ± 25%. Peak facilitation was at
50 min after injection (Fig. 2).
Baseline spontaneous activity after bicuculline was 55 ± 3 Hz
(range, 20-90 Hz). Facilitation became significant at 10 min after
agatoxin injection and was 67 ± 7 Hz
(F(3,16)=16.2; p = 0.033). Maximal facilitation was observed at 60 min after injection and
was 90 ± 4 Hz (mean), ranging from 19 to 209 Hz
(n = 16; p < 0.0001) (Fig. 3).
In many cases, a notable characteristic of the increased spontaneous
activity after agatoxin injection into the vlPAG was that the firing
changed to a burst-like pattern after an initial tonic increase of
activity; this burst-like pattern lasted throughout the 60 min
observation period.
Control injections inside and outside the vlPAG
Five WDR neurons inhibited by bicuculline in the vlPAG were tested
for injection of saline at the same site and observed over 60 min.
Saline injection in the vlPAG did not significantly affect the
nociceptive responses of A -fiber activity (p = 0.284), C-fiber activity (p = 0.113), or
spontaneous activity (p = 0.574) compared with
baseline. In seven WDR neurons, bicuculline or agatoxin injected outside the PAG, 0.5-1 mm dorsal or lateral to the border of the PAG,
did not affect trigeminal nociceptive activity in A -fiber responses
(p = 0.467), C-fiber responses
(p = 0.512) or spontaneous responses
(p = 0.418) compared with baseline.
Blood-pressure effect
Bicuculline in the vlPAG elicited a characteristic transient
decrease in blood pressure (Lovick, 1985 ; Waters and Lumb, 1997 ) of
15-20 mmHg over 60-100 sec after injection (Fig.
4B). This was not correlated
with a change in spontaneous activity and this transient blood-pressure
decrease returned to baseline before the onset of inhibition, which
outlasted the duration of the blood-pressure effect, as reported
previously (Sandkuhler et al., 1991 ; Waters and Lumb, 1997 ). In some
cases, agatoxin also affected blood pressure by inducing fluctuations
over a 30-40 mmHg range throughout the observation period. An example
is given in Figure 4. We did not observe a correlation between the
overall change in spontaneous activity and the blood-pressure
fluctuations induced by agatoxin.

View larger version (20K):
[in this window]
[in a new window]
|
Figure 3.
A, Receptive field characteristics
of a sample TNC recording showing responses to stimulation of
superficial and deep receptive fields. B, Histograms
showing the inhibition of TNC spontaneous activity after bicuculline
injection in the vlPAG and facilitation after agatoxin injection. The
blood-pressure (BP) trace shows a characteristic
transient decrease accompanying bicuculline injection in the PAG and
sporadic fluctuations observed after agatoxin injection.
Imp/s, Impulses per second.
|
|

View larger version (22K):
[in this window]
[in a new window]
|
Figure 4.
Sample experiment showing an inhibitory or
facilitatory effect of bicuculline or agatoxin microinjected into the
vlPAG, respectively, on dural stimulation-responsive neurons in the
TNC. Poststimulus histograms (i) and original
oscilloscope traces (ii) of the baseline response
(A), the response 5 min after bicuculline
injection in the PAG (B) showing
inhibition of 42%, and the response 60 min after agatoxin
injection in the PAG (C) showing facilitation of
144% are shown.
|
|
 |
DISCUSSION |
We have studied the blockade of P/Q-type calcium channels in the
caudal ventrolateral periaqueductal gray and observed its effect on
spinal trigeminal firing linked with dural stimulation. We report a
facilitation of trigeminal nociceptive activity after microinjection of
the P/Q-type calcium-channel blocker -agatoxin IVA into the vlPAG.
These results support a hypothesis for the involvement of the PAG in
trigeminal pronociception and of P/Q-type calcium channels in
trigeminal nociception.
The agatoxin-induced facilitation we observed across the A -fiber,
C-fiber, and spontaneous responses occurred within, on average, 10 min
of agatoxin injection. This is in accordance with findings of in
vitro cerebellar and hippocampal slice studies in which agatoxin
blockade showed a similar time course to take effect on postsynaptic
Purkinje and pyramidal cells (Poncer et al., 1997 ; Stephens et al.,
2001 ). Because the facilitation we observed was in A -fiber, C-fiber,
and spontaneous responses, it suggests that there are no selective
actions of the neurons on which the P/Q-type calcium channels
were blocked. It is worth noting that the relatively high level of
baseline spontaneous activity we recorded is likely to be caused
by the type of electrodes we used. Other studies investigating
the spontaneous activity of dural-responsive neurons recorded with
carbon or stainless-steel electrodes (impedance, 8-12 M ) reported
considerably lower spontaneous activity (0.05-46 Hz) as a result
of the different spatial-recruitment characteristics of the electrodes
(Burstein et al., 1998 ; Schepelmann et al., 1999 ). -agatoxin IVA is
an irreversible blocker of P/Q-type calcium channels (Mintz et al.,
1992 ); however, it also has a small effect on T-type channels in some
cells (Rusin and Moises, 1995 ), depending on the concentration of
agatoxin at the synapse. Because of difficulty in accurately
controlling the toxin concentration at all synapses in complex tissue
(Dunlap et al., 1995 ), we cannot exclude the possibility that
non-P/Q-type channels were also blocked by agatoxin. The facilitation
induced by agatoxin lasted the duration of the 60 min observation
period. That the effect appeared maximal at 60 min may only reflect
that our observation period was 60 min; an improvement of the data
could be gained by observing the effect of agatoxin for a longer period.
Nociceptive facilitation can arise by anti-analgesic or pronociceptive
effects. By injecting agatoxin into the PAG, we irreversibly blocked
P/Q-type calcium channels in a population of heterogeneous neurons. At
synaptic terminals, P/Q-type channels are required for coupling
presynaptic action potentials to the transmitter release process
(Dunlap et al., 1995 ; Sutton et al., 1999 ). As such, the channels are
in predominantly presynaptic locations. Presynaptic locations in the
PAG are positioned on GABA inhibitory interneurons and descending
projection neurons. After PAG P/Q-type channel blockade, we saw an
increase in evoked as well as spontaneous trigeminal activity.
Therefore, the neurons containing the blocked P/Q-type channels were
likely to be actively firing before agatoxin injection. This indicates
the involvement of neurons involved in tonic inhibitory maintenance of
the nociceptive response.
The PAG contains a tonically active antinociceptive GABAergic network
that operates through GABAA receptors (Reichling,
1991 ). When the GABAA antagonist bicuculline is
injected into the PAG, it excites the majority of cells in the PAG and
effectively acts by blocking the inhibition of inhibitory projection
neurons (Sandkuhler et al., 1989 ; Behbehani et al., 1990 ). This
mechanism was the basis for our use of bicuculline as a test search
stimulus to identify projections between the PAG and trigeminal
neurons. Conversely, a mechanism by which the PAG excites spinal
nociceptive neurons is by inhibition of this descending inhibitory
input (i.e., disinhibition). It is possible that the increase in
trigeminal nociceptive activity that we observed resulted from a
blockade of P/Q-type calcium channels negatively coupled to GABA
release onto an inhibitory interneuron contacting an inhibitory
projection neuron. If so, then blockade of P/Q-type calcium channels
would enhance GABA release and disinhibit the dorsal horn neuron. This
has been observed in cerebellar neurons, where 1A subunits play a
major role in mediating action potential-evoked inhibitory GABA release
in mouse Purkinje cells, and in hippocampal pyramidal cells (Poncer et al., 1997 ; Stephens et al., 2001 ). Additional studies in our model might confirm that P/Q-type calcium channels mediate such disinhibitory GABA release in the PAG.
Alternatively, rather than by disinhibition, the
agatoxin-induced facilitation might have been the result of direct
pronociceptive mechanisms. µ-opioid agonists hyperpolarize on-cells
projecting to nociceptive dorsal horn neurons (Pan et al., 1990 ).
Patch-clamp studies in dorsal root ganglion and nodose ganglion neurons
have shown that P/Q-type channels are negatively coupled with
µ-opioid receptors (Rusin and Moises, 1995 , 1998 ). The same may prove
to be the case in the PAG. Pronociception might arise from an increase in the basal excitability of dorsal horn neurons. Descending
projections from the PAG can enhance the sensitivity of nociceptive
dorsal horn neurons (Bederson et al., 1990 ; Urban et al., 1996 ).
However, in some models the tonic activation of descending facilitation is dependent on afferent input from damaged peripheral nerves (Kovelowski et al., 2000 ).
How can these experimental findings be applied to the
clinical observations of migraine and its pathophysiology? First, we have demonstrated that PAG P/Q-type calcium channels play a role in
facilitating trigeminal nociception. In migraine, this places them as
possible components of the headache process. Clinical imaging data
strongly suggest dysfunction in the region of the PAG in migraineurs.
The clinical cases of PAG lesions producing migraine-like headache
support this suggestion (Raskin et al., 1987 ; Haas et al., 1993 ; Veloso
et al., 1998 ). At the neurotransmitter level, a trigeminal-specific
part of the PAG has not been determined; however, it is possible that
those PAG-descending inhibitory neurons that target trigeminal regions
of the dorsal horn are abnormally regulated by P/Q-type calcium-channel
dysfunction in migraineurs. In conclusion, the results of this study
suggest a possible site for the dysfunctional P/Q-type calcium channels
in migraine and familial hemiplegic migraine.
 |
FOOTNOTES |
Received Sept. 24, 2001; revised Dec. 13, 2001; accepted Dec. 18, 2001.
This work was supported by the Wellcome Trust and the Migraine Trust.
T.B. is supported by the Deutsche Forschungsgemeinschaft. We thank
Simon Akerman, R. James Storer, Michele Lasalandra, Bridget Lumb, Simon
McMullan, David Bulmer, and Alexandra V. Gourine for technical advice
and support.
Correspondence should be addressed to Peter J. Goadsby, Institute of
Neurology, Queen Square, London WC1N 3BG, UK. E-mail: peterg{at}ion.ucl.ac.uk.
This article is published in
The Journal of Neuroscience, Rapid Communications Section,
which publishes brief, peer-reviewed papers online, not in print. Rapid
Communications are posted online approximately one month earlier than
they would appear if printed. They are listed in the Table of Contents
of the next open issue of JNeurosci. Cite this article as:
JNeurosci, 2002, 22:RC213 (1-6). The
publication date is the date of posting online at
www.jneurosci.org.
 |
REFERENCES |
-
Bahra A,
Matharu MS,
Buchel C,
Frackowiak RSJ,
Goadsby PJ
(2001)
Brainstem activation specific to migraine headache.
Lancet
357:1016-1017.
-
Bederson JB,
Fields HL,
Barbaro NM
(1990)
Hyperalgesia during naloxone-precipitated withdrawal from morphine is associated with increased on-cell activity in the rostral ventromedial medulla.
Somatosens Mot Res
7:185-203.
-
Behbehani MM
(1995)
Functional characteristics of the midbrain periaqueductal gray.
Prog Neurobiol
46:575-605.
-
Behbehani MM,
Jiang MR,
Chandler SD,
Ennis M
(1990)
The effect of GABA and its antagonists on midbrain periaqueductal gray neurons in the rat.
Pain
40:195-204.
-
Burstein R,
Yamamura H,
Malick A,
Strassman AM
(1998)
Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brainstem trigeminal neurons.
J Neurophysiol
79:964-982.
-
Craig PJ,
McAinsh AD,
McCormack AL,
Smith W,
Beattie RE,
Priestley JV,
Yip JLY,
Averill S,
Longbottom ER,
Volsen SG
(1998)
Distribution of the voltage-dependent calcium channel
(1A) subunit throughout the mature rat brain and its relationship to neurotransmitter pathways.
J Comp Neurol
397:251-267. -
Dunlap K,
Luebke JI,
Turner TJ
(1995)
Exocytotic Ca2+ channels in mammalian central neurons.
Trends Neurosci
18:89-98.
-
Goadsby PJ,
Zagami AS,
Lambert GA
(1991)
Neural processing of craniovascular pain: a synthesis of the central structures involved in migraine.
Headache
31:365-371.
-
Haas DC,
Kent PF,
Friedman DI
(1993)
Headache caused by a single lesion of multiple sclerosis in the periaqueductal gray area.
Headache
33:452-455.
-
Hillman D,
Chen S,
Aung TT,
Cherksey B,
Sugimori M,
Llinas RR
(1991)
Localization of P-type calcium channels in the central nervous system.
Proc Natl Acad Sci USA
88:7076-7080.
-
Hoskin KL,
Bulmer DCE,
Lasalandra M,
Jonkman A,
Goadsby PJ
(2001)
Fos expression in the midbrain periaqueductal grey after trigeminovascular stimulation.
J Anat
198:29-35.
-
Hu JW,
Dostrovsky JO,
Sessle BJ
(1981)
Functional properties of neurons in cat trigeminal subnucleus caudalis (medullary dorsal horn). I. Responses to oral-facial noxious and nonnoxious stimuli and projections to thalamus and subnucleus oralis.
J Neurophysiol
45:173-192.
-
Keay KA,
Bandler R
(1998)
Vascular head pain selectively activates ventrolateral periaqueductal gray in the cat.
Neurosci Lett
245:58-60.
-
Knight YE,
Goadsby PJ
(2001)
The periaqueductal grey matter modulates trigeminovascular input: a role in migraine?
Neuroscience
106:793-800.
-
Kors EE,
Terwindt GM,
Vermeulen F,
Fitzsimons RB,
Jardine PE,
Heywood P,
Love S,
van den Maagdenberg A,
Haan J,
Frants RR,
Ferrari MD
(2001)
Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine.
Ann Neurol
49:753-760.
-
Kovelowski CJ,
Ossipov MH,
Sun H,
Lai J,
Malan TP,
Porreca F
(2000)
Supraspinal cholecystokinin may drive tonic descending facilitation mechanisms to maintain neuropathic pain in the rat.
Pain
87:265-273.
-
Lovick TA
(1985)
Ventrolateral medullary lesions block the antinociceptive and cardiovascular responses elicited by stimulating the dorsal periaqueductal grey matter in rats.
Pain
21:241-252.
-
Malmberg AB,
Yaksh TL
(1994)
Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N-type and P-type channels inhibits formalin-induced nociception.
J Neurosci
14:4882-4890.
-
May A,
Ophoff RA,
Terwindt GM,
Urban C,
Vaneijk R,
Haan J,
Diener HC,
Lindhout D,
Frants RR,
Sandkuijl LA,
Ferrari MD
(1995)
Familial hemiplegic migraine locus on 19p13 is involved in the common forms of migraine with and without aura.
Hum Genet
96:604-608.
-
May A,
Kaube H,
Buchel C,
Eichten C,
Rijntjes M,
Juptner M,
Weiller C,
Diener HC
(1998)
Experimental cranial pain elicited by capsaicin: a PET study.
Pain
74:61-66.
-
Mintz IM,
Venema VJ,
Swiderek KM,
Lee TD,
Bean BP,
Adams ME
(1992)
P-type calcium channels blocked by the spider toxin omega-Aga-Iva.
Nature
355:827-829.
-
Molander C,
Grant G
(1995)
Spinal cord cytoarchitecture.
In: The rat nervous system, Ed 2 (Paxinos G,
ed), pp 39-44. San Diego: Academic.
-
Nebe J,
Ebersberger A,
Vanegas H,
Schaible HG
(1999)
Effects of omega-agatoxin IVA, a P-type calcium channel antagonist, on the development of spinal neuronal hyperexcitability caused by knee inflammation in rats.
J Neurophysiol
81:2620-2626.
-
Nyholt DR,
Lea RA,
Goadsby PJ,
Brimage PJ,
Griffiths LR
(1998)
Familial typical migraine: linkage to chromosome 19p13 and evidence for genetic heterogeneity.
Neurology
50:1428-1432.
-
Oliveras JL,
Woda A,
Guilbaud G,
Besson JM
(1974)
Inhibition of the jaw opening reflex by electrical stimulation of the periaqueductal gray matter in the awake, unrestrained cat.
Brain Res
72:328-331.
-
Ophoff RA,
Terwindt GM,
Vergouwe MN,
vanEijk R,
Oefner PJ,
Hoffman SMG,
Lamerdin JE,
Mohrenweiser HW,
Bulman DE,
Ferrari M,
Haan J,
Lindhout D,
vanOmmen GJB,
Hofker MH,
Ferrari MD,
Frants RR
(1996)
Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4.
Cell
87:543-552.
-
Pan ZZ,
Williams JT,
Osborne PB
(1990)
Opioid actions on single nucleus raphe magnus neurons from rat and guinea pig in vitro.
J Physiol (Lond)
427:519-532.
-
Paxinos G,
Watson C
(1998)
In: The rat brain in stereotaxic coordinates, Ed 4. London: Academic.
-
Poncer JC,
McKinney RA,
Gahwiler BH,
Thompson SM
(1997)
Either N- or P-type calcium channels mediate GABA release at distinct hippocampal inhibitory synapses.
Neuron
18:463-472.
-
Raskin NH,
Hosobuchi Y,
Lamb S
(1987)
Headache may arise from perturbation of brain.
Headache
27:416-420.
-
Reichling DB
(1991)
GABAergic neuronal circuitry in the periaqueductal gray matter.
In: The midbrain periaqueductal gray matter: functional, anatomical, and neurochemical organisation (Depaulis A,
Bandler R,
eds), pp 329-344. New York: Plenum.
-
Reynolds DV
(1969)
Surgery in the rat during electrical analgesia induced by focal brain stimulation.
Science
164:444-445.
-
Rusin KI,
Moises HC
(1995)
µ-opioid receptor activation reduces multiple components of high-threshold calcium current in rat sensory neurons.
J Neurosci
15:4315-4327.
-
Rusin KI,
Moises HC
(1998)
µ-opioid and GABAB receptors modulate different types of Ca2+ currents in rat nodose ganglion neurons.
Neuroscience
85:939-956.
-
Sandkuhler J,
Willmann E,
Fu QG
(1989)
Blockade of GABAA receptors in the midbrain periaqueductal gray abolishes nociceptive spinal dorsal horn neuronal activity.
Eur J Pharmacol
160:163-166.
-
Sandkuhler J,
Willmann E,
Fu QG
(1991)
Characteristics of midbrain control of spinal nociceptive neurons and nonsomatosensory parameters in the pentobarbital-anesthetized rat.
J Neurophysiol
65:33-48.
-
Schepelmann K,
Ebersberger A,
Pawlak M,
Oppmann M,
Messlinger K
(1999)
Response properties of trigeminal brain stem neurons with input from dura mater encephali in the rat.
Neuroscience
90:543-554.
-
Stephens GJ,
Morris NP,
Fyffe REW,
Robertson B
(2001)
The Ca(v)2.1/
1A (P/Q-type) voltage-dependent calcium channel mediates inhibitory neurotransmission onto mouse cerebellar Purkinje cells.
Eur J Neurosci
13:1902-1912. -
Sutton KG,
McRory JE,
Guthrie H,
Murphy TH,
Snutch TP
(1999)
P/Q-type calcium channels mediate the activity-dependent feedback of syntaxin-1A.
Nature
401:800-804.
-
Urban MO,
Jiang MC,
Gebhart GF
(1996)
Participation of central descending nociceptive facilitatory systems in secondary hyperalgesia produced by mustard oil.
Brain Res
737:83-91.
-
Veloso F,
Kumar K,
Toth C
(1998)
Headache secondary to deep brain implantation.
Headache
38:507-515.
-
Waters AJ,
Lumb BM
(1997)
Inhibitory effects evoked from both the lateral and ventrolateral periaqueductal grey are selective for the nociceptive responses of rat dorsal horn neurones.
Brain Res
752:239-249.
-
Weiller C,
May A,
Limmroth V,
Juptner M,
Kaube H,
Schayck RV,
Coenen HH,
Diener HC
(1995)
Brain stem activation in spontaneous human migraine attacks.
Nat Med
1:658-660.
-
Welch KMA,
Nagesh V,
Aurora SK,
Gelman N
(2001)
Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness?
Headache
41:629-637.
-
Westenbroek RE,
Sakurai T,
Elliott EM,
Hell JW,
Starr TVB,
Snutch TP,
Catterall WA
(1995)
Immunochemical identification and subcellular distribution of the
(1a) subunits of brain calcium channels.
J Neurosci
15:6403-6418.
Copyright © Society for Neuroscience 0270-6474//$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
M. A. Rocca, A. Ceccarelli, A. Falini, B. Colombo, P. Tortorella, L. Bernasconi, G. Comi, G. Scotti, and M. Filippi
Brain Gray Matter Changes in Migraine Patients With T2-Visible Lesions: A 3-T MRI Study
Stroke,
July 1, 2006;
37(7):
1765 - 1770.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Pietrobon
Migraine: New Molecular Mechanisms
Neuroscientist,
August 1, 2005;
11(4):
373 - 386.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
H. L. Agler, J. Evans, H. M. Colecraft, and D. T. Yue
Custom Distinctions in the Interaction of G-protein {beta} Subunits with N-type (CaV2.2) Versus P/Q-type (CaV2.1) Calcium Channels
J. Gen. Physiol.,
May 27, 2003;
121(6):
495 - 510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Silberstein and K.M.A. Welch
Painkiller headache
Neurology,
October 8, 2002;
59(7):
972 - 974.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tottene, T. Fellin, S. Pagnutti, S. Luvisetto, J. Striessnig, C. Fletcher, and D. Pietrobon
Familial hemiplegic migraine mutations increase Ca2+ influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons
PNAS,
October 1, 2002;
99(20):
13284 - 13289.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|